Radiotherapy commissioning and tariff—how can we deliver advanced, innovative, and personalised radiotherapy?
British Journal of Radiology · 2025
DOI: 10.1093/bjr/tqaf253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Imogen Powell Brown und 9 weiteren Autor:innen. Beteiligte Einrichtung: NW Radiotherapy Specialised Services Clinical Network, Manchester M20 4BX, United Kingdom. Hauptthemen laut MEDLINE: Radiotherapy, Precision Medicine, Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NW Radiotherapy Specialised Services Clinical Network Oversight Group.
Abstract (Originalsprache)
Radiotherapy practices have changed significantly over recent decades with the introduction of increasingly personalised approaches to preparation and treatment and the use of a wider range of imaging technology, treatment techniques and software such as Artificial Intelligence (AI). The lack of development of the radiotherapy tariff, which remunerates services for radiotherapy delivery, has contributed to poor adoption rates and inequitable access for patients to new advanced treatment technologies and software across England. The radiotherapy tariff has a potential to be a lever to drive innovation across the system, if it is routinely updated to respond to latest clinical consensus. The commissioning of radiotherapy services is being transferred from NHS England to Integrated Care Boards (ICBs), in their emerging role as ‘strategic commissioners’. Along with wider reform to funding mechanisms set out in the 10 Year Health Plan, this presents an opportunity to reshape the commissioning and tariff structures for radiotherapy services to better reflect contemporary radiotherapy practice. This paper explores the limitations of current funding arrangements for radiotherapy. It proposes recommendations to ensure that providers are supported to deliver more productive, innovative and value-based radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NW Radiotherapy Specialised Services Clinical Network, Manchester M20 4BX, United Kingdom.
- Lancaster University, Lancaster LA1 4YW, United Kingdom.
- The Christie, Manchester M20 4BX, United Kingdom.
- The Clatterbridge Cancer Centre, Liverpool L7 8YA, United Kingdom.
- Cheshire and Merseyside Cancer Alliance, Liverpool L7 8YA, United Kingdom.
ORCID-Profile: Daniel Hutton
Förderung
- NW Radiotherapy Specialised Services Clinical Network Oversight Group
Zitieren
APA
Powell Brown, I., Hutton, D., Thorp, N., Thomson, J., MacKay, R., Hacker, L., Ashmore, L., Hayes, J., Archer, J., & Rowbottom, C. (2025). Radiotherapy commissioning and tariff—how can we deliver advanced, innovative, and personalised radiotherapy?. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf253
Vancouver
Powell Brown I, Hutton D, Thorp N, Thomson J, MacKay R, Hacker L, et al. Radiotherapy commissioning and tariff—how can we deliver advanced, innovative, and personalised radiotherapy?. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf253
BibTeX
@article{PowellBrown2025,
author = {Powell Brown, Imogen and Hutton, Daniel and Thorp, Nicola and Thomson, James and MacKay, Ran and Hacker, Liesl and Ashmore, Lisa and Hayes, John and Archer, John and Rowbottom, Carl},
title = {Radiotherapy commissioning and tariff—how can we deliver advanced, innovative, and personalised radiotherapy?},
journal = {British Journal of Radiology},
year = {2025},
doi = {10.1093/bjr/tqaf253}
}
EUVIMED